Research Assistant at Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, China
Ms. Hua Jin is a highly accomplished researcher in hepatology and immunology. She holds an M.B. in clinical medicine and advanced degrees (M.S. and M.D.) in hepatology from Capital Medical University and Beijing Friendship Hospital, China. Currently, she works as a researcher at the Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital. Her research focuses on liver injury and immune responses, particularly the role of OX40 in hepatic ischemia-reperfusion injury and drug-induced liver damage. She has co-authored numerous high-impact publications in journals like JCI Insight, British Journal of Pharmacology, and Cell Reports. Her groundbreaking work has earned her recognition, including the prestigious American Transplant Congress Young Investigator Award in 2021. In addition to her research, she has presented her findings at major international conferences, including the Asian Pacific Association for the Study of the Liver and the American Transplant Congress.
Professional Profile
Education
Ms. Hua Jin has a strong academic background in clinical medicine and hepatology. She completed her undergraduate studies in Clinical Medicine at Chongqing Medical University in China, earning her M.B. degree from 2009 to 2014. Following this, she pursued advanced training in hepatology, earning her M.S. degree from the Experimental and Translational Research Center at Beijing Friendship Hospital, Capital Medical University, from 2015 to 2018. Building on this foundation, she furthered her expertise by obtaining an M.D. in hepatology, also from the Experimental and Translational Research Center, between 2018 and 2021. This rigorous education provided Ms. Jin with a deep understanding of both clinical and research aspects of hepatology, setting the stage for her current work in immunology and liver disease. Her academic achievements reflect a commitment to advancing knowledge in medical research, particularly in the areas of liver injury and immune system regulation.
Professional Experience
Ms. Hua Jin has extensive professional experience in the field of medical research, particularly in hepatology and immunology. After completing her advanced degrees, she began her research career as a Research Assistant at the Immunology Research Center for Oral and Systemic Health at Beijing Friendship Hospital, Capital Medical University, from 2021 to 2024. During this time, she worked on critical research related to immune responses in liver injury, with a focus on the role of OX40 in liver diseases. In 2024, she transitioned to her current role at the Medical Research Center, Beijing Institute of Respiratory Medicine, and Beijing Chao-Yang Hospital, where she continues her work in hepatology and immunology. Throughout her career, Ms. Jin has contributed to numerous high-impact research projects, authored multiple publications in prestigious journals, and presented her work at leading international conferences, establishing herself as a promising young investigator in the field of liver disease and immune system regulation.
Research interest
Ms. Hua Jin’s research interests primarily focus on hepatology, immunology, and liver diseases. Her work investigates the immune mechanisms underlying liver injury, particularly the role of immune checkpoints like OX40 in hepatic ischemia-reperfusion injury, drug-induced liver injury, and non-alcoholic steatohepatitis (NASH). She is particularly interested in how immune responses, both innate and adaptive, contribute to liver diseases, aiming to identify potential therapeutic targets for improving liver function and preventing damage. Her research also delves into the cellular and molecular dynamics of immune cells such as neutrophils and T cells in liver injury. Through the application of advanced techniques like single-cell transcriptomics, she explores the heterogeneity of immune cell populations and their roles in inflammation and liver repair. Ms. Jin’s work seeks to bridge the gap between basic immunology and clinical hepatology, with the goal of developing novel, immune-based therapeutic strategies for liver diseases.
Award and Honor
Ms. Hua Jin has received notable recognition for her research contributions, highlighting her prominence in the fields of hepatology and immunology. In 2021, she was honored with the prestigious American Transplant Congress Young Investigator Award, which acknowledges exceptional young researchers making significant strides in transplant medicine and immunology. This award reflects the high regard her work has garnered within the scientific community. Additionally, Ms. Jin has published multiple influential papers in top-tier journals, such as JCI Insight, Cell Reports, and British Journal of Pharmacology, further cementing her status as a rising star in medical research. Her innovative studies on immune responses in liver injury and the role of immune checkpoints like OX40 have gained widespread recognition. Furthermore, she has presented her research at prominent international conferences, including the Asian Pacific Association for the Study of the Liver and American Transplant Congress, showcasing her contributions to the global medical research community.
Conclusion
Hua Jin demonstrates the core qualities of an outstanding researcher: academic excellence, groundbreaking contributions, and recognition within his field. His work on immune responses in liver injury is cutting-edge and contributes valuable insights to the medical community. With continued growth in his research portfolio and a potential increase in his mentorship and international networking, he could further enhance his impact. Based on these strengths, Hua Jin is highly deserving of consideration for the Best Researcher Award.
Publications Top Noted
- “Rebalancing liver-infiltrating CCR3+ and CD206+ monocytes improves diet-induced NAFLD”
- Authors: Sun, G., Wang, Y., Yang, L., Zhang, Z., Zhang, D.
- Year: 2023
- Citations: 5
- Erratum to “Isolation and purification of immune cells from the liver”
- Authors: Shi, W., Wang, Y., Zhang, C., Zhang, D., Sun, G.
- Year: 2023
- Citations: 0
- “OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis”
- Authors: Xu, L., Tian, D., Zhou, M., Zhang, D., Wu, J.
- Year: 2022
- Citations: 2
- “Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis”
- Authors: Chen, S., Lv, T., Sun, G., Zhang, D., Jia, J.
- Year: 2022
- Citations: 6
- “The Critical and Diverse Roles of CD4–CD8– Double Negative T Cells in Nonalcoholic Fatty Liver Disease”
- Authors: Li, C., Du, X., Shen, Z., Zhang, D., Sun, G.
- Year: 2022
- Citations: 11
- “CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis”
- Authors: Sun, G., Zhao, X., Li, M., Zhang, Z., Zhang, D.
- Year: 2021
- Citations: 22
- “Transcriptome landscape of double negative T cells by single-cell RNA sequencing”
- Authors: Yang, L., Zhu, Y., Tian, D., Zhao, Y., Zhang, D.
- Year: 2021
- Citations: 26
- “Dietary Inorganic Nitrate Protects Hepatic Ischemia-Reperfusion Injury Through NRF2-Mediated Antioxidative Stress”
- Authors: Li, S., Jin, H., Sun, G., Zhang, D., Wang, S.
- Year: 2021
- Citations: 14
- “Isolation and purification of immune cells from the liver”
- Authors: Shi, W., Wang, Y., Zhang, C., Zhang, D., Sun, G.
- Year: 2020
- Citations: 34
- “Critical role of OX40 in drug-induced acute liver injury”
- Authors: Zhang, C., Jin, H., Wang, Y., Sun, G., Zhang, D.
- Year: 2020
- Citations: 4
